刺激响应纳米材料用于针对性药物输送在炎症性肠病:进步和新兴方向
Wenpeng Huang1,2,3, Jessica C Hsu2,3, Jingwei Zhou4,3
1Department of Nuclear Medicine, Peking University First Hospital, Beijing 100034, China.
响应刺激的纳米材料为炎症性肠病 (IBD) 提供有针对性的药物输送. 这些智能系统通过在炎症部位释放药物来改善IBD治疗,减少副作用.
科学领域:
- 生物医学工程 生物医学工程
- 胃肠病学 胃肠病学
- 纳米技术纳米技术
背景情况:
- 炎症性肠病 (IBD) 是一种慢性胃肠道疾病,治疗选择有限.
- 对IBD的传统疗法面临着诸如药物过早释放和全身毒性等挑战.
- 刺激响应纳米材料为IBD的向药物输送提供了一种新的方法.
研究的目的:
- 系统地审查刺激响应纳米材料药物输送系统在IBD治疗的最新进展.
- 要突出这些纳米材料如何利用IBD微环境来增强药物向和释放.
- 确定基于纳米材料的IBD治疗的当前挑战和未来方向.
主要方法:
- 对IBD的刺激反应性纳米材料的最新文献进行系统审查.
- 对应IBD病理特征的纳米材料设计原则的分析.
- 评估这些系统的治疗结果和安全概况.
主要成果:
- 刺激响应纳米材料在IBD模型中显示了改善的药物向和特定部位释放.
- 这些系统可以提高治疗效果,同时最大限度地减少系统性副作用.
- 在开发用于IBD的智能纳米材料药物输送系统方面取得了重大进展.
结论:
- 刺激响应纳米材料在促进IBD治疗方面具有显著的前景.
- 需要解决可扩展制造,长期安全和临床翻译方面的挑战.
- 未来的研究应该专注于减少变异性,确保安全性和整合个性化医疗.
更多相关视频
09:51Screening Bioactive Nanoparticles in Phagocytic Immune Cells for Inhibitors of Toll-like Receptor Signaling
Published on: July 26, 2017
06:57Development of an Antigen-driven Colitis Model to Study Presentation of Antigens by Antigen Presenting Cells to T Cells
Published on: September 18, 2016
相关概念视频
Drugs for Treatment of Ulcerative Colitis in IBD
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
